CASP3 and cancer: The killing of cancer cells by the compound was likely to occur through induction of apoptosis, evidenced by significant increase in caspase 3/7 activity (Figure 2A), PARP cleavage (Figure 2B), annexin V/propidium iodide labelling of cells (Figure 3).